Monday, November 9, 2026||
MultiKhabarMultiKhabar

BDR Pharma buys majority stake in oral care biz of Acme Formulation

Share:WhatsAppFacebookX (Twitter)Telegram
BDR Pharma buys majority stake in oral care biz of Acme Formulation
Photo / Coverage: The Hindu Business Line
EXECUTIVE SUMMARY

The transaction values the business at about ₹2,370 crore ($250 million), said sources close to the deal

Key Takeaways

  • BDR Pharma buys majority stake in oral care biz of Acme Formulation.

The transaction values the business at about ₹2,370 crore ($250 million), said sources close to the deal

Share:WhatsAppFacebookX (Twitter)Telegram

Read Complete Original Article

Published originally on The Hindu Business Line

Visit Publisher Site →

Related News

🇮🇳 India
Multikhabar App

All Information In One Place

Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!

Get it on Google Play